Vol 53, No 5 (2019)
Letter to the Editors
Published online: 2019-09-20
Submitted: 2019-07-21
Accepted: 2019-08-01
Get Citation

Is vitamin D deficiency a reliable risk factor for multiple sclerosis development?

Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Monika Chorąży, Barbara Mroczko, Jan Kochanowicz, Alina Kułakowska
DOI: 10.5603/PJNNS.a2019.0039
·
Pubmed: 31538658
·
Neurol Neurochir Pol 2019;53(5):388-389.

paid access

Vol 53, No 5 (2019)
Letter to the Editors
Published online: 2019-09-20
Submitted: 2019-07-21
Accepted: 2019-08-01

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

vitamin 25(0H)D, multiple sclerosis

About this article
Title

Is vitamin D deficiency a reliable risk factor for multiple sclerosis development?

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 53, No 5 (2019)

Pages

388-389

Published online

2019-09-20

DOI

10.5603/PJNNS.a2019.0039

Pubmed

31538658

Bibliographic record

Neurol Neurochir Pol 2019;53(5):388-389.

Keywords

vitamin 25(0H)D
multiple sclerosis

Authors

Joanna Tarasiuk
Katarzyna Kapica-Topczewska
Monika Chorąży
Barbara Mroczko
Jan Kochanowicz
Alina Kułakowska

References (8)
  1. Bartosik-Psujek H, Psujek M. Vitamin D as an immune modulator in multiple sclerosis. Neurol Neurochir Pol. 2019; 53(2): 113–122.
  2. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004; 79(3): 362–371.
  3. Fitzgerald KC, Munger KL, Köchert K, et al. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurol. 2015; 72(12): 1458–1465.
  4. Sintzel MB, Rametta M, Reder AT. Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther. 2018; 7(1): 59–85.
  5. Smolders J, Hupperts R, Barkhof F, et al. SOLAR study group. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci. 2011; 311(1-2): 44–49.
  6. Golan D, Halhal B, Glass-Marmor L, et al. Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties. BMC Neurol. 2013; 13: 60.
  7. Zheng C, He L, Liu L, et al. The efficacy of vitamin D in multiple sclerosis: A meta-analysis. Mult Scler Relat Disord. 2018; 23: 56–61.
  8. Płudowski P, Ducki C, Konstantynowicz J, et al. Vitamin D status in Poland. Pol Arch Med Wewn. 2016; 126(7-8): 530–539.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl